Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

In a report released today, Jailendra Singh from Truist Financial assigned a Buy rating to Phreesia (PHR – Research Report). The company’s ...

Phreesia, Inc. (NYSE:PHR – Get Free Report) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Twelve analysts have rated the ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

Fintel reports that on January 8, 2025, RBC Capital upgraded their outlook for Phreesia (NYSE:PHR) from Sector Perform to Outperform. Analyst Price Forecast Suggests 8.40% Upside As of December 24 ...

Phreesia, Inc. (NYSE:PHR), a leading healthcare technology company specializing in patient intake management and workflow optimization, has been garnering attention from analysts and investors alike.